New peptides players in metabolic disorders

Area of Science:

• Endocrinology and Metabolism
• Molecular Biology

Background:

• Adipokines, hormones from adipose tissue, are key in metabolic disorders.
• Adropin and preptin are newly identified peptides with significant, yet not fully understood, roles in metabolic regulation.
• Preptin, derived from pro-IGF-II, enhances insulin secretion and stimulates osteoblasts.
• Adropin, encoded by the Enho gene, regulates energy homeostasis, fatty acid metabolism, and insulin sensitivity.

Purpose of the Study:

• To explore the roles of adropin and preptin in metabolic regulation.
• To investigate the association of adropin and preptin levels with metabolic syndrome and related diseases.
• To highlight the potential of preptin in bone health and osteoporosis prevention.

Main Methods:

• Literature review of existing studies on adropin and preptin.
• Analysis of peptide concentrations in relation to metabolic disorders.
• Examination of the physiological effects of adropin and preptin on metabolic pathways and bone cells.

Main Results:

• Adropin and preptin concentrations are significantly altered in metabolic syndrome and associated conditions like obesity, type 2 diabetes, PCOS, NAFLD, and cardiovascular disease.
• Preptin demonstrates a positive effect on osteoblast proliferation, differentiation, and survival, suggesting a role in bone metabolism.
• Adropin is implicated in maintaining metabolic homeostasis, controlling fatty acid metabolism, and preventing insulin resistance and dyslipidemia.

Conclusions:

• Adropin and preptin are important peptides involved in metabolic homeostasis and carbohydrate metabolism.
• Altered levels of these peptides are observed in various metabolic disorders, indicating their pathogenic relevance.
• Preptin's anabolic effect on bone suggests a potential therapeutic role in preventing osteoporosis.